Latest From Vitrolife AB
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in June 2016.
In Vitro Diagnostics
- Laboratory Testing Services
- Consumables, Central Supplies
- Diagnostic Equipment & Supplies
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
- Monitoring Equipment & Devices
- Surgical Equipment & Devices
- Therapeutic Areas
- Gynecological, Urological
- Western Europe
- Parent & Subsidiaries
- Vitrolife AB
- Senior Management
Thomas Axelsson, CEO
Mikael Engblom, CFO
Maria Forss, VP, Bus. Dev. & Global Mktg.
Christer Silversand, PhD, CSO
- Contact Info
Phone: 31 721 80 00
P.O. Box 9080 Göteborg, SE-400 92
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.